Hilar cholangiocarcinoma
- PMID: 23919104
- PMCID: PMC3731523
- DOI: 10.4251/wjgo.v5.i7.113
Hilar cholangiocarcinoma
Abstract
Hilar cholangiocarcinoma (HC) is a rare tumor. It accounts for 2/3 of the tumors of the biliary tract. Untreated, prognosis is very poor. Surgery is the only therapy that offers the possibility of cure but is technically very complex. With recent improvements in the therapeutic strategies applied by multidisciplinary teams, survival rates in the different series currently range from 25% to 45%. A group of experts devoted to HC (pathologists, gastroenterologists, radiologists, surgeons and oncologists) have reviewed and updated every open question in HC in a special issue.
Keywords: Cancer; Cholangiocarcinoma; Hilar; Klatskin; Perihilar; Review; Surgery.
References
-
- de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118:4737–4747. - PubMed
-
- DeOliveira ML, Clavien PA. A common language to describe perihilar cholangiocarcinoma. Br J Surg. 2012;99:885–886. - PubMed
-
- Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129–140. - PubMed
-
- Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, Bresadola F, Calise F, Dalla Valle R, D’Amico DF, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147:26–34. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources